ADVANCE INJECTABLES EXCELLENCE Trademark Information

Trademark by Sagent Pharmaceuticals, Inc.

Pharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, ...

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ADVANCE INJECTABLES EXCELLENCE
Status/Status Date:
THIRD EXTENSION - GRANTED
12/14/2020
Serial Number: 87905941
Filing Date: 5/3/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical injectable drugs for the treatment and prevention of cancer, cardiovascular disease, infections, pain, arthritis, psoriasis, diabetes, multiple sclerosis, anemia, hepatitis, hemophilia, osteoporosis, asthma, cystic fibrosis, pancreatitis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, systemic lupus erythematous, macular degeneration, migraines, growth hormone deficiency, chronic idiopathic urticaria, infertility, paroxysmal nocturnal hemoglobinuria, pneumonia, respiratory syncytial virus, varicella virus, human papillomavirus, and meningococcal disease
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/14/2019
Last Applicant/Owner:
Sagent Pharmaceuticals, Inc.
Schaumburg, IL 60195
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("INJECTABLES")
Correspondent:
BRYAN CAVE LEIGHTON PAISNER LLP
211 NORTH BROADWAY, SUITE 3600
ST. LOUIS MO 63102
Current Status:
THIRD EXTENSION - GRANTED
12/14/2020
Correspondent Search:
MARK A. PASKAR is a correspondent of ADVANCE INJECTABLES EXCELLENCE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on